Research news from Bhupesh Prusty

I don’t really know. I ‘think’ there are many different diseases that need to be excluded before CFS is made the diagnosis. I have a gut feeling a portion of us have undiagnosed illnesses that mimics CFS.

Dr Nath ran into this when doing his big study. Those patients were removed from the study. I hope they publish what the alternative diagnosis's were.

 

I'm used to viewing everyone in the ME universe as a saleman and fast-talker. If they're not blabbing for money, they might just be blabbing out of pride. Event totally honest people deceive themselves.

 

https://twitter.com/user/status/1655314087859896320

 

That's a heck of a journey in a quarter of an hour!

I do hope it's a bit more than a theory. We've had enough of them to fill Beaufort's Dyke and we're still not much wiser.

 

If not mistaken, Dr. Prusty said he had a 'model.'

 

OK but where is Stop 2? Didn’t he say he was going to the UK meeting as well?

ETA yeah this one

http://www.investinme.org/IIMEC15.shtml#speakers

So hopefully he won’t say that he is going to present the important results at the UK meeting.

 

From the earlier posted Dr Bhupesh Prusty, Molecular Virologist — TLC SESSIONS page:

For those who have trouble concentrating/listening, a commenter named Richard made a summary:

 

That's in three days already.

I'm finding it very hard not to get excited about it today.
(Yes, I know etc., etc., it's just what inner me does.)

 

Not sure if it was posted somewhere already, Prusty recently received a 25.000 € grant from the German Association for ME/CFS: https://www.mecfs.de/forschungsfoerderung-2022/

Automatically translated with DeepL:
"The second project is being conducted by PD Dr. Bhupesh Kumar Prusty at the Institute of Virology and Immunobiology, Julius Maximilians University, Würzburg, Germany. The study investigates the relationship between viral infections (especially HHV-6, HHV-7 and EBV), autoimmunity and mitochondria in the development and progression of ME/CFS. The investigators* are using a novel method called Targeted Immunoglobulin Associated Proteomics (TIgAP) to identify proteins that may be targets for ME/CFS-specific antibodies.

The main objective of this study is to apply immunoglobulin fractions from ME/CFS patients* and healthy controls (n = 10 each) to different primary cell types and isolate proteins that specifically interact with IgG fractions from ME/CFS patients*. Subsequently, these proteins will be identified by mass spectrometry and their interactions with IgG will be validated in further studies."

 

On a slightly random but related note, I'm actually travelling to Wurzburg for work in a few weeks, to play a gig.
Maybe I'll see if Bhupesh wants to come!

 

https://twitter.com/user/status/1655753331032162305


updated

https://twitter.com/user/status/1655732770218311684

 

In response to question: "Are you saying that you won’t mention the biomarker?"

 

Yeah, I don't like this game. Was gonna watch his talk in Berlin later this week, can't be arsed now.